Investors bumped its shares higher following a decent, if unspectacular, earnings report.Investors happily greeted the latest news from Abbott Laboratories (ABT 1.52%) on Hump Day. After the storied healthcare company unveiled its third-quarter results, those folks traded its stock up by 1.5%. That was good enough to edge past the S&P 500 index's 0.5% gain.A pair of modest beatsFor the quarter, Abbott's revenue totaled just under $10.64 billion, for year-over-year growth of almost 5%. Non-GAAP (adjusted) ne ...